Cita APA (7a ed.)

Akter, A., & Alam, M. (2022). Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis. Brac University.

Cita Chicago Style (17a ed.)

Akter, Anika, y Marzia Alam. Pharmacokinetics, Safety, Efficacy and Immunogenicity of Adalimumab Biosimilar ABP-501in Rheumatoid Arthritis and Plaque Psoriasis. Brac University, 2022.

Cita MLA (8a ed.)

Akter, Anika, y Marzia Alam. Pharmacokinetics, Safety, Efficacy and Immunogenicity of Adalimumab Biosimilar ABP-501in Rheumatoid Arthritis and Plaque Psoriasis. Brac University, 2022.